| Annual · values | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -8.58 M USD | -16.32 M USD | -757000 USD | -1.85 M USD | 8.13 M USD | -14.87 M USD | -1.32 M USD | -3.35 M USD | -3.58 M USD | -5.72 M USD | -4.13 M USD | -4.38 M USD |
| Depreciation & Amortization | 27.71 M USD | 30.76 M USD | 27.49 M USD | 22.77 M USD | 20.25 M USD | 9.87 M USD | 2.42 M USD | 857939 USD | 664831 USD | 374202 USD | 197938 USD | 311590 USD |
| Stock-Based Compensation | 10.07 M USD | 19.70 M USD | 22.81 M USD | 20.08 M USD | 15.35 M USD | 8916 USD | 16.52 M USD | 5.48 M USD | 3.55 M USD | 3.12 M USD | 881706 USD | 678119 USD |
| Capital Expenditures | 16.44 M USD | 17.25 M USD | 38.78 M USD | 22.11 M USD | 23.88 M USD | 8.92 M USD | 5.34 M USD | 2.91 M USD | 1.71 M USD | 1.06 M USD | 70130 USD | 138886 USD |
| Cash Flow from Investing | 250.32 M USD | 176.81 M USD | 36.05 M USD | -59.68 M USD | -469.25 M USD | -382.31 M USD | -62.93 M USD | -12.88 M USD | -1.80 M USD | -1.07 M USD | -70130 USD | -138886 USD |
| Cash Flow from Financing | -21.07 M USD | -161.53 M USD | -23.80 M USD | -39.17 M USD | 564.34 M USD | 385.58 M USD | 74.15 M USD | 38.53 M USD | 15.90 M USD | 6.06 M USD | 5.23 M USD | 4.33 M USD |
| Dividends Paid | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock Buybacks | 10.01 M USD | — | — | 37.96 M USD | 0 USD | 0 USD | — | — | — | — | — | — |
| Free Cash Flow | -25.02 M USD | -33.58 M USD | -39.54 M USD | -23.96 M USD | -15.76 M USD | -23.78 M USD | -6.66 M USD | -6.27 M USD | -5.30 M USD | -6.78 M USD | -4.20 M USD | -4.52 M USD |
Cryoport Inc. is a global provider specializing in temperature-controlled logistics solutions for the life sciences industry. Its primary function is to ensure safe and efficient transportation of temperature-sensitive materials, including biological samples, pharmaceuticals, and other life sciences products. Notable for its comprehensive solutions, Cryoport offers a range of services including cryogenic transportation, monitoring, and logistics management, which are vital for maintaining product integrity and regulatory compliance. The company's offerings significantly impact sectors such as biotechnology, pharmaceuticals, and medical research, where precision and reliability are crucial. Cryoport's logistic services support the entire lifecycle of biopharmaceuticals, from research and development to clinical trials and commercialization. Cryoport's role in the financial market is underscored by its contribution to sustaining critical supply chains in the rapidly growing life sciences sector, making it a cornerstone for companies that rely on precise and secure logistics for their valuable materials. Headquartered in Nashville, Tennessee, Cryoport's innovation and commitment to quality make it a key player in enhancing the global capabilities of temperature-controlled logistic solutions for sensitive biological materials.